Top 10 Mid-size Pharma Companies (mainly specialty) in Europe in 2021 by Revenues

Perrigo Co Plc, Hikma Pharmaceuticals Plc, Indivior Plc, Galapagos NV, and ALK-Abello AS are the top 5 mid-size pharmaceutical companies (mainly specialty) in Europe in 2021 by revenue. Cumulatively, the top 10 Mid-size Pharma Companies (mainly specialty) in Europe generated revenue of $10,091 million, the highest revenue was generated by Perrigo Co Plc ($4,139 million), followed by Hikma Pharmaceuticals Plc ($2,553 million) and Indivior Plc ($791 million) while Genfit SA ($101 million) stood the lowest. Ireland -based Perrigo Co Plc is one of the leading mid-size pharma companies in Europe in 2021 by revenue. It is an over-the-counter consumer good and specialty pharmaceutical company. It develops, manufactures, and distributes over-the-counter products, generic, specialty pharmaceutical companies, nutritional products, and infant formulas and foods. The company reported revenue of $4,139 million. The company classifies its operations into three business segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI) and employed 9,900 people. The UK-based Hikma Pharmaceuticals Plc is one of the leading mid-size pharma companies in Europe in 2021 by revenue. It develops, manufactures, and markets branded and non-branded generics and in-licensed products. The company specializes in the areas of cardiovascular, diabetes, central nervous system (CNS), cancer, dermatology, genitourinary system, hormones, and respiratory system. The company generated revenue of $2,553 million. The company classifies its business into three main reportable segments: Injectables, Generics, and Branded, and employed 8,703 employees.